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Abstract 
 
Neurofibromatosis type 1 (NF1) is caused, in 4.7–11% of cases, by large deletions 
encompassing the NF1 gene and its flanking regions within 17q11.2. Different types of large 
NF1 deletion occur which are distinguishable by their breakpoint location and underlying 
mutational mechanism. Most common are the type-1 NF1 deletions of 1.4-Mb which exhibit 
recurrent breakpoints caused by non-allelic homologous recombination (NAHR), also termed 
unequal crossover. Here, we analysed 37 unrelated families of patients with de novo type-1 
NF1 deletions by means of short tandem repeat (STR) profiling to determine the parental 
origin of the deletions. We observed that 33 of the 37 type-1 deletions were of maternal origin 
(89.2% of cases; p < 0.0001). Analysis of the patients’ siblings indicated that, in 14 
informative cases, ten (71.4%) deletions resulted from interchromosomal unequal crossover 
during meiosis I. Our findings indicate a strong maternal parent-of-origin bias for type-1 NF1 
deletions. A similarly pronounced maternal transmission bias has been reported for recurrent 
copy number variants (CNVs) within 16p11.2 associated with autism, but not so far for any 
other NAHR-mediated pathogenic CNVs. Region-specific genomic features are likely to be 
responsible for the maternal bias in the origin of both the 16p11.2 CNVs and type-1 NF1 
deletions. 
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Introduction 
Large deletions encompassing the NF1 gene region at 17q11.2 (also termed NF1 
microdeletions) are detected in 4.711% of patients with neurofibromatosis type 1 (NF1; 
MIM #162200) (Cnossen et al. 1997; Rasmussen et al. 1998; Kluwe et al. 2004; Zhang et al. 
2015). Frequently, these deletions exhibit recurrent breakpoints and are mediated by non-
allelic homologous recombination (NAHR), also referred to as unequal crossover. However, 
different types of large NF1 deletion have been identified which are distinguishable by the 
size and locations of their breakpoints. Most frequent are type-1 NF1 deletions of 1.4-Mb 
accounting for 70-80% of all large NF1 deletions (Pasmant et al. 2010; Messiaen et al. 2011). 
Type-1 NF1 deletions are caused by NAHR between highly homologous low-copy repeats 
(LCRs) termed NF1-REPa and NF1-REPc (Dorschner et al. 2000; Jenne et al. 2001; López-
Correa et al. 2001). Type-1 NF1 deletions are characterized by breakpoint recurrence since 
most of the breakpoints are located within the NAHR hotspots referred to as paralogous 
recombination sites 1 and 2 (PRS1 and PRS2) (Forbes et al. 2004; De Raedt et al. 2006; 
Bengesser et al. 2014; Hillmer et al. 2016, 2017). Type-2 NF1 deletions encompass only 1.2-
Mb and are mediated by NAHR between the SUZ12 gene and its pseudogene SUZ12P (Roehl 
et al. 2010; Vogt et al. 2012). Type-2 NF1 deletions comprise 10-20% of all large NF1 
deletions (Kehrer-Sawatzki et al. 2004; Messiaen et al. 2011). Type-3 NF1 deletions are 
characterized by breakpoints located within NF1-REPb and NF1-REPc and are also mediated 
by NAHR (Bengesser et al. 2010; Pasmant et al. 2010; Zickler et al., 2012). However, type-3 
deletions are rare, accounting for only 1.44% of all large NF1 deletions (Pasmant et al. 2010; 
Messiaen et al. 2011).  
    In addition to large NF1 deletions with recurrent breakpoints, atypical NF1 deletions have 
been identified which exhibit non-recurrent breakpoints. These atypical NF1 deletions are not 
mediated by NAHR but instead by occur via DNA double strand break repair or replication-
associated mechanisms (Vogt et al. 2014 and references therein). At least 10% of all large 
NF1 deletions are atypical (Pasmant et al. 2010; Messiaen et al. 2011). They are 
heterogeneous in terms of breakpoint location, size and the number of genes located within 
the deleted region (reviewed by Kehrer-Sawatzki et al. 2017). 
    The various types of NF1 microdeletion are distinguishable not only by breakpoint position 
and underlying mechanism but also by the frequency of somatic mosaicism with normal cells 
not harbouring the deletion. Type-2 NF1 deletions, caused by NAHR between SUZ12 and 
SUZ12P1, are frequently of postzygotic origin (Kehrer-Sawatzki et al. 2004; Steinmann et al. 
2007); thus, at least 63% of all type-2 NF1 deletions are associated with somatic mosaicism 
(Vogt et al. 2012). Atypical NF1 deletions are also frequently mosaic; among the 17 atypical 
NF1 deletion patients investigated by Vogt et al. (2014), 10 patients (59%) exhibited somatic 
mosaicism with normal cells. By contrast, only a small proportion (2–4%) of type-1 NF1 
microdeletions are of postzygotic origin and associated with somatic mosaicism (Messiaen et 
al. 2011).  
    Early studies reported that large NF1 deletions are often of maternal origin but the deletions 
analysed were not characterized with regard to their size, type and underlying mutational 
mechanism (Lazaro et al. 1996; Upadhyaya et al. 1998). López-Correa et al. (2000) analysed 
six NF1 deletions that had been shown to be of type-1, and all six of them were of maternal 
origin. The study of López-Correa at al. (2000) also included a smaller NF1 deletion, not of 
type-1, but this deletion was of paternal origin. Although these findings hinted at a maternal 
bias for type-1 NF1 deletions, the number of deletions analysed by López-Correa et al. (2000) 
was still small. In the study presented here, we investigated a rather larger number of 
confirmed type-1 NF1 deletions (N=37) and successfully identified their parental origin. 
Further, we determined the chromosomal origin of 14 of these type-1 NF1 deletions, in 
particular ascertaining whether they were mediated by interchromosomal or 
intrachromosomal NAHR. We observed a strong maternal parent-of-origin bias for type-1 
NF1 deletions which might be attributable to gender-specific differences in recombination 
rates or chromatin conformations.  
 
 
Patient data, Materials and Methods 
We analysed 37 patients with de novo type-1 NF1 deletions and their unaffected relatives who 
were collected at the Department of Neurology, University Hospital Hamburg Eppendorf, 
Germany. The deletions of these patients had exhibiting breakpoints located within the highly 
homologous low-copy repeats NF1-REPa and NF1-REPc as determined by MLPA and long-
range breakpoint-spanning PCRs (Supplementary Table S1). The primers used for the 
breakpoint-spanning PCRs have been reported previously (Hillmer et al. 2017). Genomic 
DNA from the patients and their relatives was extracted from blood cells or saliva using 
Oragene•DNA (OG-250) DNA collection tubes (Genotek). The DNA extracted from saliva 
samples is derived from a mixture of buccal epithelial cells and blood cells (up to 74% of the 
DNA isolated from saliva is derived from white blood cells; Thiede et al. 2000). The patients 
and their family members provided written informed consent. This study was approved by the 
insititutional review boards of the University of Ulm and the University Medical Center 
Hamburg-Eppendorf.  
 
STR profiling 
Short tandem repeats (STRs), also termed microsatellite markers, were investigated by PCR 
and fragment analysis of the PCR products in order to determine the parental and 
chromosomal origin of the deletions. The primers used for these assays are listed in 
Supplementary Table S2. The primers were either labelled at their 5’ends with 6-FAM 
(Fluorescein) or HEX (Hexachloro-Fluorescein). PCR products were amplified using the 
AmpliTaq Gold™ 360 DNA polymerase (Applied Biosystems) and separated by capillary gel 
electrophoresis on an ABI 3130xl genetic analyzer (Applied Biosystems). The GeneScan™ 
500 ROX™ size standard was used to determine the size of the allele peaks.  
 
Recombination rate analysis 
Male and female recombination rates across the type-1 NF1 deletions region were taken from 
Kong et al. (2010) and visualized by means of the UCSC Genome Browser 
(https://genome.ucsc.edu/). 
 
 
Results  
Microsatellite marker analysis of DNA derived from the NF1 patients and their parents 
revealed that 33 of the 37 type-1 NF1 deletions analysed were of maternal origin (89.2%) 
whereas only four were of paternal origin (10.8%) (Table 1). Hence, our findings indicate a 
strong maternal bias for the origin of type-1 NF1 deletions (p < 0.0001, two-tailed binomial 
test). 
The chromosomal origin of 14 of the 37 type-1 deletions was identified by means of marker 
analysis of the unaffected siblings of the patients harbouring the deletions in question. The 
chromosomal origin of a deletion indicates whether it has been caused by inter- or intra-
chromosomal NAHR. If NAHR occurs between homologous chromosomes, it is referred to as 
interchromosomal NAHR which occurs during meiosis I, schematically indicated in 
Supplementary Figure S1. Alternatively, if NAHR takes place between sister chromatids of 
one chromosome or within one chromatid of a single chromosome, it is referred to as 
intrachromosomal NAHR which most likely occurs during meiosis II (Supplementary Figures 
S2 and S3). The analysis of unaffected siblings indicated the phase of the markers and hence 
the haplotypes of the transmitting parents. If the patient exhibited an exchange of markers 
flanking the deletion region as compared with the haplotypes of the transmitting parent, then 
the deletion must have been caused by interchromosomal NAHR as exemplified in Figure 1. 
By contrast, no change of the haplotype phase of markers flanking the deletion is indicative of 
intrachromosomal NAHR (Figure 1). We noted that interchromosomal NAHR was 
responsible for ten (71.4%) of the 14 type-1 NF1 deletions in which the chromosomal origin 
of the deletion had been identified. By contrast, four deletions (28.6%) were caused by 
intrachromosomal NAHR (Table 1). If only the deletions of maternal origin are considered, 
then nine of the 11 maternal deletions (81.8%) were mediated by interchromosomal NAHR. 
In the study of López-Correa et al. (2000), marker analysis of unaffected siblings of type-1 
NF1 deletion patients was informative in five of the six families investigated and all five 
deletions were mediated by maternal interchromosomal NAHR. If our results and those of 
López-Correa et al. (2000) are taken together, 14 of the 16 type-1 NF1 deletions analysed 
were of maternal, interchromosomal origin (87.5%, p = 0.0042, two-tailed binomial test). 
These findings indicate a preference for interchromosomal crossover for in the context of 
maternal type-1 deletions. If only the deletions of paternal origin are considered, then two of 
the three paternal deletions were mediated by intrachromosomal NAHR. 
 
 
Discussion 
Non-allelic homologous recombination (NAHR), also referred to as unequal crossover 
between LCRs during meiosis, is the mechanism responsible for recurrent disease-associated 
copy number variants (CNVs) including germline type-1 NF1 deletions (reviewed by Watson 
et al. 2014). In contrast to CNVs with recurrent breakpoints, those de novo CNVs with non-
recurrent breakpoints are caused by a variety of different mutational mechanisms including 
microhomology-mediated break-induced replication (MMBIR) and fork stalling associated 
with template switching (FoSTeS) (reviewed in Carvalho and Lupski, 2016). As an alternative 
to replication-associated mechanisms, non-recurrent CNVs can be caused by various DNA 
double strand repair mechanisms that are not dependent upon sequence homology at the 
breakpoints, e,g, non-homologous end joining (NHEJ) (reviewed in Weckselblatt and Rudd, 
2015). Previous studies have indicated that de novo non-recurrent CNVs, in particular 
deletions, are preferentially of paternal origin (Thomas et al. 2006a; Itsara et al. 2010; Hehir-
Kwa et al. 2011; Sibbons et al. 2012; Ma et al. 2017). This bias could be explicable in terms 
of the higher number of cell divisions (and hence replications) in the male as compared with 
the female germline. Whilst the number of oogonia in females is fixed at birth and will not 
increase later in life, self-renewing spermatogenic stem cells undergo continuous proliferation 
and replication during a male’s lifespan (reviewed by Drost and Lee, 1995; Wilson Sayres and 
Makova, 2011; Griswold, 2016). The higher number of cell divisions (and replications) in the 
male germ line is likely to be the cause of the paternal parent-of-origin bias for de novo 
mutations (Kong et al. 2012; Rahbari et al. 2016) and may also explain the paternal bias for 
large structural imbalances such as non-recurrent CNVs (Ma et al. 2017). 
    In contrast to de novo CNVs with non-recurrent breakpoints, recurrent CNVs such as type-
1 NF1 deletions exhibit a strong maternal parent-of-origin bias. In the study presented here, a 
considerable excess of maternally derived type-1 NF1 deletions was observed (33 out of 37 
deletions, 89.2% of cases; p < 0.0001, two-tailed binomial test). A strong maternal bias for 
type-1 NF1 deletions has previously been reported by López-Correa et al. (2000) but their 
study was very limited in size since it included only six confirmed type-1 NF1 deletions. If 
our results and those of López-Correa et al. (2000) are combined, 39 of 43 type-1 NF1 
deletions analysed have been of maternal origin (90.7%; p < 0.0001, two-tailed binomial test). 
A similarly pronounced maternal parent-of-origin bias has been reported for de novo disease-
associated duplications and deletions of a 550 kb region on chromosome 16p11.2 (Duyzend et 
al. 2016) (Table 2). Such a high level of maternal bias in transmission has not however been 
reported for any other type of recurrent disease-associated CNV. Hence, the 16p11.2 CNVs 
and type-1 NF1 deletions are so far without precedent in terms of their extremely high 
maternal parent-of-origin bias.  
    A rather more subtle but nevertheless still significant bias in favour of a maternal origin has 
been reported for the 22q11.2 microdeletions associated with DiGeorge and Velocardiofacial 
syndrome (Table 2) (Thomas et al. 2006b; Delio et al. 2013). However, the extent of this 
maternal bias was much lower than that observed for type-1 NF1 deletions and the CNVs at 
16p11.2. The significantly higher recombination rates in the 16p11.2 critical region in females 
as compared to males have been suggested as the explanation of the maternal bias for the 
16p11.2 CNVs (Kong et al. 2010; Duyzend et al. 2016). We also observed differences 
between female and male recombination maps involving 7-17.5-fold higher recombination 
rates in females than in males across the type-1 NF1 deletion region, a finding which could be 
responsible for the maternal parent-of-origin bias for type-1 NF1 deletions (Supplementary 
Figure S4). 
Higher recombination rates in females than in males have also been noted in the 22q11.2 
microdeletion region associated with DiGeorge and Velocardiofacial syndrome (Delio et al. 
2013). Taken together, these findings imply an association between gender-specific 
recombination rate differences across certain genomic regions and parent-of-origin bias for 
CNVs. However, the consideration of recombination rates across CNV regions may not be 
precise enough in this context; instead, it might be more informative to investigate local 
recombination rates at CNV breakpoints. However, the breakpoints of NAHR-mediated 
CNVs are located within LCRs. The assessment of recombination rates within these paralogs 
is difficult owing to their complex variation patterns characterized by the occurrence of 
multiple shared SNPs between the paralogues resulting from frequent non-allelic homologous 
gene conversion without crossover (Rozen et al. 2003; Pavlicek et al. 2005; De Raedt et al. 
2006; Lindsay et al. 2006; Guo et al. 2016; Hillmer et al. 2017). Consequently, these 
paralogous genomic regions are not well represented in the currently available recombination 
maps. Future high-resolution analysis of recombination rates within LCRs at NAHR 
breakpoints will be necessary to confirm an association between parent-of-origin bias and 
gender-specific recombination rate differences.  
    In addition to recurrent CNVs exhibiting a maternal parent-of-origin bias, there are also 
some with a paternal bias, including the CNVs causing Sotos syndrome and Charcot-Marie-
Tooth disease type 1A (Lopes et al. 1998, Miyake et al. 2003, Visser et al. 2005) (Table 2). 
By contrast, other NAHR-mediated CNVs such as those causing Williams-Beuren syndrome, 
Smith-Magenis syndrome and Potocki-Lupski syndrome, do not exhibit any gender bias of 
origin (Table 2). These differences indicate that a gender-of-origin bias for recurrent CNVs is 
not a feature that is inherent to NAHR as the causative mechanism but is instead dependent 
upon genomic region-specific features. Alternatively, the occurrence of a parent-of-origin bias 
for a CNV may be associated with negative selection against oocytes or spermatocytes 
harbouring the CNV in question. It therefore cannot be excluded that negative selection 
against spermatocytes harbouring type-1 NF1 deletions contributes to the observed maternal 
parent-of-origin bias for these deletions. 
Remarkably, type-1 NF1 deletions are associated with the loss of two tumour suppressor 
genes, NF1 and SUZ12. Among the other recurrent CNVs listed in Table 2, only the 3-Mb 
deletions at 22q11.2 causing Velocardiofacial or DiGeorge syndrome lead to the loss of a 
tumour suppressor gene, in this case, LZTR1. It is unclear as yet if the CNV-mediated loss of 
these tumour suppressor genes has any impact upon the maternal inheritance bias of the 
respective CNVs.  
    The vast majority of type-1 NF1 deletions are of meiotic origin and are not associated with 
somatic mosaicism with normal cells not harbouring the deletion. Only 2-4% of patients with 
type-1 NF1 exhibit somatic mosaicism with normal cells (Messiaen et al. 2011). In the study 
presented here, we investigated the chromosomal origin of 14 type-1 NF1 deletions (11 of 
maternal and three of paternal origin; Table 1). If only the deletions of maternal origin are 
considered and our results are combined with those of López-Correa et al. (2000), then 14 of 
the 16 type-1 NF1 deletions, for which the chromosomal origin could be determined, were of 
interchromosomal origin (87.5% of cases; p = 0.0042, two-tailed binomial test). This indicates 
a preference for maternal interchromosomal NAHR events causing type-1 NF1 deletions. 
Since interchromosomal exchange derives from unequal crossover during meiosis I, the 
predominance of interchromosomal NAHR events causing type-1 NF1 deletions confirms that 
these deletions are predominantly of meiotic origin. By contrast, no significant parent-of-
origin bias has been observed for type-2 NF1 deletions which are mostly of postzygotic origin 
and mediated by intrachromosomal NAHR (Roehl et al. 2010).  
    The predominance of maternally derived type-1 NF1 deletions mediated by 
interchromosomal NAHR suggests that there are gender-specific differences in the meiotic 
processes that promote ectopic chromosome synapsis between the LCRs NF1-REPa and NF1-
REPc, a prerequisite for NAHR or unequal crossover. Ectopic synapsis between these LCRs 
is likely to be promoted by specific chromatin conformations which are epigenetically 
regulated. Early germ cells have been shown to undergo a multitude of epigenetic changes 
that accompany their development and the onset of meiotic recombination (reviewed by Kota 
and Feil, 2010; Sin et al. 2015; Sun et al. 2017; Maezawa et al. 2018). In relation to putative 
epigenetic differences between male and female germ cells, what is important is that the 
initiation of meiotic recombination occurs at completely different times during the human 
male and female lifespans. In human oocytes of the primordial follicle, meiotic recombination 
is initiated very early on during fetal development and is already complete before birth. Only 
after a pause of many years do some of these oocytes enter into the first meiotic division upon 
hormonal stimulation. By contrast, male germ cells are not involved in meiotic recombination 
during the fetal period but instead remain dormant until hormonally stimulated to further 
divide in the sexually mature adult (reviewed by El Yakoubi and Wassmann, 2017). Hence, 
early germ cells are likely to exhibit gender-specific differences in their epigenetically 
regulated chromatin conformation which could conceivably include the LCRs NF1-REPa and 
NF1-REPc. One consequence of these differences might be a higher rate of ectopic synapsis 
and unequal crossover between these LCRs in female germ cells than in their male 
counterparts resulting in the observed maternal parent-of-origin bias for type-1 NF1 deletions.  
An intriguing sexual dimorphism has recently been observed pertaining to the width of the 
synaptonemal complex in the mouse (Agostinho et al. 2018). The synaptonemal complex is a 
proteinaceous tripartite, ladder-like structure that links homologous chromosomes and 
mediates recombination, in particular crossover formation, during meiotic prophase I 
(reviewed by Zickler and Kleckner, 2015). If gender-specific differences in the synaptonemal 
complex were also to exist in humans, they could influence the frequency of equal as well as 
unequal crossovers between certain LCRs. Further studies are now urgently required to 
address these issues in order to identify the underlying cause(s) of the strong parent-of-origin 
biases characterizing some CNVs including the type-1 NF1 deletions studied here.    
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Legend to Figure 
Figure 1: Chromosomal origin of type-1 NF1 deletions as determined by the analysis of 
microsatellite markers located on chromosome 17 (nucleotide positions given according to 
hg19) performed in order to determine the parental origin of the deletions and whether they 
had been caused by interchromosomal NAHR (as in the case of the deletion in patient 450) or 
intrachromosomal NAHR (as in the case of the deletion in patient SB94).  
The analysis of unaffected siblings indicated the phase of the markers and hence the 
haplotypes of the transmitting parents. The numbers in the coloured columns indicate the 
lengths of the PCR fragments representing the alleles in the individuals investigated. Markers 
within the red rectangles are located within the NF1 microdeletion region. Alleles highlighted 
in yellow are informative with respect to the parental origin of the deletion. Grey marking 
denotes alleles that were not informative. del: allele is deleted. 
 
Table 1 
Parental origin of 37 de novo type-1 NF1 deletions. The chromosomal origin of 14 deletions 
was determined by analysis of the siblings of the patients.  
 
Number of deletions of 
maternal or paternal origin/ 
total number of deletions  
Number of deletions of 
maternal  
origin 
paternal  
origin 
maternal origin mediated by paternal origin mediated by 
interchromo-
somal NAHR 
intrachromo-
somal NAHR 
interchromo-
somal NAHR 
intrachromo-
somal NAHR 
33/37 
(89.2%) 
 
4/37  
(10.8%) 
 
9/11  
(81.8%) 
2/11  
(18.2%) 
1/3  
(33.3%) 
2/3  
(66.7%)  
 
Table 2 
Parental and chromosomal origin of recurrent pathogenic NAHR-mediated copy number variants (CNVs). CNVs occurring in genomic regions harbouring 
imprinted genes were not considered.  
Disorder [MIM #] Disease-causing CNV/ 
chromosomal region 
Number of CNVs of maternal or paternal origin/ 
total number of CNVs investigated (proportion, 
p-value for the two-tailed binomial test [reference] 
Number of CNVs of intra- or inter-
chromosomal origin/ total number of CNVs 
investigated  
Williams-Beuren syndrome [194050] deletion of 1.5 Mb/ 7q11.23 333 maternal /639 (52.1%, p = 0.307),  306 paternal /639 (47.9%) [1] 
61/84 (72.6%) interchromosomal 
23/84 (27.3%) intrachromosomal [2] 
22q11.2 deletion syndrome including 
Velocardiofacial syndrome [192430] 
and DiGeorge syndrome [188400]  
deletion of 3 Mb/ 22q11.2 
219 maternal /389 (56.2%, p = 0.0148),  
170 paternal /389 (43.8%) [3] 
31/34 (91.2%) interchromosomal  
3/34 (8.8%) intrachromosomal [6] 
465 maternal /810 (57.4%, p < 0.0001), 
345 paternal /810 (42.6%) [4]  
185 maternal /318 (58.2%, p =  0.0042),  
133 paternal /318 paternal (41.8%) [5] 
Chromosome 16p11.2 deletion 
syndrome [611913] deletion of ~550 kb/ 16p11.2 
59 maternal /66 (89.4%, p < 0.0001), 
7 paternal / 66 (10.6%) [7] 
26/50 (52%) interchromosomal 
24/50 (48%) intrachromosomal [7] 
Chromosome 16p11.2 duplication 
syndrome [614671] duplication of ~550 kb/ 16p11.2 
12 maternal /13 (92.3%, p = 0.0034),  
1 paternal /13 (7.7%) [7] 
7/12 (66.6%) intrachromosomal  
4/12 (33.3%) interchromosomal [7] 
17q21.31 microdeletion syndrome 
[610443] deletion of 500-650 kb/ 17q21.31 
12 paternal /20 (60%, p = 0.5034), 
8 maternal /20 (40%) [8] not determined 
Smith-Magenis syndrome 
[182290] deletion of 3.7 Mb/ 17p11.2 
19 maternal /32 (59.3%, p = 0.3771), 
13 paternal /32 (40.7%) [9,10] not determined 
Potocki-Lupski syndrome [610883] duplication of 3.7 Mb/ 17p11.2 23 paternal /41 (56.1%, p = 0.5327), 18 maternal /41 (43.9%) [11] 
38/59 (64.4%) interchromosomal  
21/59 (35.6%) intrachromosomal [11] 
Sotos syndrome [117550] deletion of 1.9 Mb/ 5q35 
18 paternal /20 (90%, p = 0.0004), 
2 maternal /20 (10%) [12] 
6/8 (75%) intrachromosomal  
2/8 (25%) interchromosomal [12] 
16 paternal/ 18 (88.9%, p =  0.0013), 
2 maternal /18 (11.1%) [13] not determined 
Charcot-Marie-Tooth disease type 1A 
CMT1A [118220] duplication of 1.5 Mb/ 17p12 
32 paternal /34 (94.1%, p < 0.0001), 
2 maternal /34 (5.9%) [14] 
32/34 (94.1%) interchromosomal 
2/34 (5.9%) intrachromosomal [14] 
Hereditary neuropathy with liability to 
pressure palsies (HNPP) [162500]) deletion of 1.5 Mb/ 17p12 
3 maternal /4 
1 paternal /4 [15] 2 intrachromosomal [15] 
[1] According to Gilbert-Dussardier et al. (1995), Dutly and Schinzel (1996), Perez-Jurado et al. (1996), Urbán et al. (1996), Robinson et al. (1996), Baumer et al. (1998), Bayés et al. (2003), 
Thomas et al. (2006b), Hobart et al. (2010), Dutra et al. (2011). [2] According to Dutly and Schinzel (1996), Urbán et al. (1996), Baumer et al. (1998), Bayés et al. (2003), Thomas et al. (2006b). 
[3] According to the original results reported by Delio et al. (2013). [4] According to the combined original results reported by Delio et al. (2013) and previously reported studies. [5] According to 
the original results of Thomas et al. (2006b) and previously reported studies summarized by these authors. [6] According to Baumer et al. (1998), Trost et al. (2000) and Saitta et al. (2004). 
[7] Duyzend et al. (2016). [8] Koolen et al. (2008). [9] Greenberg et al. (1991). [10] Juyal et al. (1996). [11] Sun et al. (2013). [12] Miyake et al. (2003). [13] Visser et al. (2005). [14] Lopes et al. 
(1998). [15] Lopes et al. (1997). 
